MYC and Miyoshi myopathy: In total, genes affecting several biological pathways have been tightened to MM development risk, including histone modification and chromatin remodeling, transcription, and co-transcriptional RNA maturation, IRF4-MYC regulatory network, B-cell differentiation, genome stability, and telomere maintenance (see Table S3).